2,454 followers
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China #lymphoma #lymsm https://t.co/9V22ujAUXA
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China #lymphoma #lymsm https://t.co/9V22ujAUXA
New research: A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China: Chidamide has demonstrated significant clinical benefits for patients with relapsed/refractory (R/R) PTCL… https://t.